Coherus BioSciences to Participate at Upcoming November Investor Conferences

Rhea-AI Summary

Coherus BioSciences, Inc. announced that senior management will participate in several investor conferences, including Truist Securities BioPharma Symposium, UBS Biopharma Conference, and Evercore ISI HealthCONx Conference. The presentations will be webcasted and available on the Coherus website.

REDWOOD CITY, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus“, Nasdaq: CHRS) today announced that senior management will participate in the following investor conferences:

• Truist Securities BioPharma Symposium In New York City on Wednesday, November 8, 2023, for 1x1 meetings only.
• UBS Biopharma Conference in Miami on Thursday, November 9, 2023, a fireside chat presentation at 11:30 a.m. Eastern Time will be webcast.
• 6th Annual Evercore ISI HealthCONx Conference in Miami on November 28-30, 2023, a fireside chat presentation on November 30th at 12:30 p.m. Eastern Time will be webcast.

A live audio webcast and an archive of the presentations from UBS Biopharma and Evercore ISI HealthCONx conferences will be available on the investors’ page of the Coherus website at http://investors.coherus.com.

Coherus Contact Information:
Jami Taylor
VP, Investor Relations
IR@coherus.com

FAQ

What conferences will Coherus BioSciences participate in?

Coherus BioSciences will participate in Truist Securities BioPharma Symposium, UBS Biopharma Conference, and Evercore ISI HealthCONx Conference.

Will the presentations be webcasted?

Yes, the presentations from the UBS Biopharma and Evercore ISI HealthCONx conferences will be webcasted.

Where can I access the webcasted presentations?

The webcasted presentations will be available on the investors' page of the Coherus website at http://investors.coherus.com.

What is the contact information for Coherus BioSciences?

The contact information for Coherus BioSciences is Jami Taylor, VP of Investor Relations, at IR@coherus.com.